Zkusit zdarma
Erasca, Inc.

Erasca, Inc.

ERAS
Cena:
$ 11.24
-0.37 (-3.19%)
Valuace
70
Růst
38
Zdraví
75
Souhrn Finanční data Pro investory Předpovědi Zprávy Dividendy Zisky Návštěvnost webu Akcionáři
Souhrn
Finanční data
Pro investory
Předpovědi
Zprávy
Dividendy
Zisky
Návštěvnost webu
Akcionáři

Zprávy

Zahraniční články
Tiskové zprávy
Dokumenty ke stáhnutí
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Erasca, Inc. - ERAS

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Erasca, Inc. - ERAS

15:45 21-05-2026

NEW YORK, May 21, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors ...

Erasca, Inc. (ERAS) Shares Crater 48%, Wiping Out $2.8 Billion of Market Cap; Hagens Berman Investigating Intellectual Property Questions Regarding Lead Asset

Erasca, Inc. (ERAS) Shares Crater 48%, Wiping Out $2.8 Billion of Market Cap; Hagens Berman Investigating Intellectual Property Questions Regarding Lead Asset

9:00 21-05-2026

SAN FRANCISCO, May 21, 2026 /PRNewswire/ -- Investors in Erasca, Inc. (NASDAQ: ERAS) saw the price o...

ERAS INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving Erasca, Inc.

ERAS INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving Erasca, Inc.

19:00 19-05-2026

NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP continues its investigation on behalf...

ERASCA INVESTOR ALERT: Bragar Eagel & Squire, P.C. is Investigating Erasca, Inc. on Behalf of Erasca Stockholders and Encourages Investors to Contact the Firm

ERASCA INVESTOR ALERT: Bragar Eagel & Squire, P.C. is Investigating Erasca, Inc. on Behalf of Erasca Stockholders and Encourages Investors to Contact the Firm

18:53 19-05-2026

Bragar Eagel & Squire, P.C.  Litigation Partner  Brandon Walker  Encourages Investors Who Suffere...

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Erasca, Inc. - ERAS

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Erasca, Inc. - ERAS

17:47 19-05-2026

NEW YORK, May 19, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of invest...

Erasca, Inc. (ERAS) Shares Crater 48%, Wiping Out $2.8 Billion of Market Cap; Hagens Berman Investigating Intellectual Property Questions Regarding Lead Asset

Erasca, Inc. (ERAS) Shares Crater 48%, Wiping Out $2.8 Billion of Market Cap; Hagens Berman Investigating Intellectual Property Questions Regarding Lead Asset

10:25 19-05-2026

SAN FRANCISCO, May 19, 2026 (GLOBE NEWSWIRE) -- Investors in Erasca, Inc. (NASDAQ: ERAS) saw the pri...

Erasca, Inc. (ERAS) Shares Crater 48%, Wiping Out $2.8 Billion of Market Cap; Hagens Berman Investigating Intellectual Property Questions Regarding Lead Asset

Erasca, Inc. (ERAS) Shares Crater 48%, Wiping Out $2.8 Billion of Market Cap; Hagens Berman Investigating Intellectual Property Questions Regarding Lead Asset

10:25 19-05-2026

SAN FRANCISCO, May 19, 2026 (GLOBE NEWSWIRE) -- Investors in Erasca, Inc. (NASDAQ: ERAS) saw the pri...

Biotech Fund Sells $44.5 Million Erasca Stake After Massive 700% Rally

Biotech Fund Sells $44.5 Million Erasca Stake After Massive 700% Rally

15:40 18-05-2026

This clinical-stage biotech develops targeted therapies for RAS/MAPK pathway cancers, advancing a pi...

Erasca Stock Is Up 715%. Here’s Why One Biotech Fund Still Bought $68 Million More

Erasca Stock Is Up 715%. Here’s Why One Biotech Fund Still Bought $68 Million More

13:58 17-05-2026

This clinical-stage biotech targets RAS/MAPK pathway cancers with a pipeline of novel small molecule...

Erasca Touts 'Eye-Popping' ERAS-0015 Lung Cancer Data, FDA Path at BofA Conference

Erasca Touts 'Eye-Popping' ERAS-0015 Lung Cancer Data, FDA Path at BofA Conference

15:06 16-05-2026

Erasca NASDAQ: ERAS executives said the company sees multiple potential development paths for its RA...

Acuta Capital Bet on Erasca (ERAS) and Targeted Cancer Treatments With a 354,575 Share Buy

Acuta Capital Bet on Erasca (ERAS) and Targeted Cancer Treatments With a 354,575 Share Buy

10:41 16-05-2026

This San Diego biotech develops targeted therapies for RAS/MAPK-driven cancers, advancing several cl...

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Erasca, Inc. - ERAS

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Erasca, Inc. - ERAS

0:00 15-05-2026

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Erasca, Inc. - ERAS...

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Erasca, Inc. - ERAS

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Erasca, Inc. - ERAS

23:01 14-05-2026

NEW YORK, May 14, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors ...

ERAS SHAREHOLDER ALERT: Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws Violations

ERAS SHAREHOLDER ALERT: Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws Violations

20:00 14-05-2026

NEW YORK, May 14, 2026 (GLOBE NEWSWIRE) -- The law firm of  Kirby McInerney LLP reminds investors o...

ERASCA INVESTOR ALERT: Bragar Eagel & Squire, P.C. is Investigating Erasca, Inc. on Behalf of Erasca Stockholders and Encourages Investors to Contact the Firm

ERASCA INVESTOR ALERT: Bragar Eagel & Squire, P.C. is Investigating Erasca, Inc. on Behalf of Erasca Stockholders and Encourages Investors to Contact the Firm

17:52 14-05-2026

Bragar Eagel & Squire, P.C.  Litigation Partner  Brandon Walker  Encourages Investors Who Suffere...

Erasca, Inc. (ERAS) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Erasca, Inc. (ERAS) Presents at Bank of America Global Healthcare Conference 2026 Transcript

20:50 13-05-2026

Erasca, Inc. (ERAS) Presents at Bank of America Global Healthcare Conference 2026 Transcript...

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Erasca, Inc. - ERAS

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Erasca, Inc. - ERAS

16:56 12-05-2026

NEW YORK, May 12, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of invest...

Erasca: 'Hold' On Substantial RAS Targeting ERAS-0015 But With Two Key Risks

Erasca: 'Hold' On Substantial RAS Targeting ERAS-0015 But With Two Key Risks

18:25 11-05-2026

I initiate Erasca (ERAS) with a "Hold" rating due to promising phase 1 ERAS-0015 data but significan...

Erasca Reports First Quarter 2026 Business Updates and Financial Results

Erasca Reports First Quarter 2026 Business Updates and Financial Results

16:01 11-05-2026

Robust monotherapy efficacy and generally well-tolerated safety results observed during dose escalat...

Erasca Announces Clinical Trial Collaboration and Supply Agreement with Merck to Evaluate ERAS-0015 in Combination with KEYTRUDA® (Pembrolizumab)

Erasca Announces Clinical Trial Collaboration and Supply Agreement with Merck to Evaluate ERAS-0015 in Combination with KEYTRUDA® (Pembrolizumab)

7:00 11-05-2026

ERAS-0015, a potentially best-in-class pan-RAS molecular glue, is being evaluated in combination wit...

close

ERASCA TO PRESENT AT UPCOMING CONFERENCES IN FEBRUARY

05-02-2026
SAN DIEGO, FEB. 05, 2026 (GLOBE NEWSWIRE) -- ERASCA, INC. (NASDAQ: ERAS), A CLINICAL-STAGE PRECISION...
Více zde

ERASCA ANNOUNCES CLOSING OF UPSIZED PUBLIC OFFERING OF COMMON STOCK, INCLUDING FULL EXERCISE OF UNDERWRITERS' OPTION TO PURCHASE ADDITIONAL SHARES

23-01-2026
SAN DIEGO, JAN. 23, 2026 (GLOBE NEWSWIRE) -- ERASCA, INC. (NASDAQ: ERAS), A CLINICAL-STAGE PRECISION...
Více zde

ERASCA ANNOUNCES PRICING OF UPSIZED PUBLIC OFFERING OF COMMON STOCK

21-01-2026
SAN DIEGO, JAN. 21, 2026 (GLOBE NEWSWIRE) -- ERASCA, INC. (NASDAQ: ERAS), A CLINICAL-STAGE PRECISION...
Více zde

ERASCA ANNOUNCES PROPOSED PUBLIC OFFERING OF $150 MILLION OF COMMON STOCK

20-01-2026
SAN DIEGO, JAN. 20, 2026 (GLOBE NEWSWIRE) -- ERASCA, INC. (NASDAQ: ERAS), A CLINICAL-STAGE PRECISION...
Více zde

ERASCA ANNOUNCES PROMISING EARLY CLINICAL DATA FOR ERAS-0015 AND 2026-2027 MILESTONES

12-01-2026
ENCOURAGING EARLY CLINICAL ACTIVITY, INCLUDING CONFIRMED PARTIAL RESPONSES IN MULTIPLE TUMOR TYPES W...
Více zde

ERASCA TO PRESENT AT THE 44TH ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE

06-01-2026
SAN DIEGO, JAN. 06, 2026 (GLOBE NEWSWIRE) -- ERASCA, INC. (NASDAQ: ERAS), A CLINICAL-STAGE PRECISION...
Více zde

HALLADOR ENERGY ADVANCES EXPANSION INTO NATURAL GAS POWER GENERATION THROUGH ERAS APPLICATION

16-12-2025
TERRE HAUTE, IND., DEC. 16, 2025 (GLOBE NEWSWIRE) -- HALLADOR ENERGY COMPANY (NASDAQ: HNRG) (“HALL...
Více zde

ERASCA TO PRESENT AT THE 8TH ANNUAL EVERCORE HEALTHCARE CONFERENCE

25-11-2025
SAN DIEGO, NOV. 25, 2025 (GLOBE NEWSWIRE) -- ERASCA, INC. (NASDAQ: ERAS), A CLINICAL-STAGE PRECISION...
Více zde

ERASCA REPORTS THIRD QUARTER 2025 BUSINESS UPDATES AND FINANCIAL RESULTS

12-11-2025
U.S. COMPOSITION OF MATTER PATENT PROTECTION THROUGH 2043 FOR POTENTIAL BEST-IN-CLASS PAN-RAS MOLECU...
Více zde

ERASCA ANNOUNCES ISSUANCE OF A U.S. PATENT COVERING PAN-RAS MOLECULAR GLUE ERAS-0015

06-11-2025
THE ISSUED PATENT PROVIDES INTELLECTUAL PROPERTY PROTECTION FOR ERAS-0015 AND RELATED COMPOSITIONS U...
Více zde

ERASCA TO PRESENT AT UPCOMING CONFERENCES IN NOVEMBER

04-11-2025
SAN DIEGO, NOV. 04, 2025 (GLOBE NEWSWIRE) -- ERASCA, INC. (NASDAQ: ERAS), A CLINICAL-STAGE PRECISION...
Více zde

ERASCA TO PRESENT AT THE MORGAN STANLEY 23RD ANNUAL GLOBAL HEALTHCARE CONFERENCE

02-09-2025
SAN DIEGO, SEPT. 02, 2025 (GLOBE NEWSWIRE) -- ERASCA, INC. (NASDAQ: ERAS), A CLINICAL-STAGE PRECISI...
Více zde

ERASCA REPORTS SECOND QUARTER 2025 BUSINESS UPDATES AND FINANCIAL RESULTS

12-08-2025
EFFICIENT EXECUTION ACCELERATED CLINICAL ENTRY OF PAN-RAS MOLECULAR GLUE ERAS-0015 AND PAN-KRAS INH...
Více zde

ERASCA ANNOUNCES IND CLEARANCE FOR POTENTIAL FIRST-IN-CLASS AND BEST-IN-CLASS PAN-KRAS INHIBITOR ERAS-4001

02-06-2025
BOTH ERAS-4001 AND POTENTIAL BEST-IN-CLASS PAN-RAS MOLECULAR GLUE ERAS-0015 RECEIVED IND CLEARANCE I...
Více zde

ERASCA TO PRESENT AT UPCOMING INVESTOR CONFERENCES IN JUNE

29-05-2025
SAN DIEGO, MAY 29, 2025 (GLOBE NEWSWIRE) -- ERASCA, INC. (NASDAQ: ERAS), A CLINICAL-STAGE PRECISION...
Více zde

ERASCA REPORTS FIRST QUARTER 2025 BUSINESS UPDATES AND FINANCIAL RESULTS

13-05-2025
EARLY ENTRY OF RAS-TARGETING FRANCHISE INTO CLINIC ENABLED BY STRONG EXECUTION INITIAL PHASE 1 MONOT...
Více zde

ERASCA ANNOUNCES EARLY CLINICAL ADVANCEMENT AND PRIORITIZATION OF RAS-TARGETING FRANCHISE COUPLED WITH MORE THAN 3 YEARS OF PROJECTED CASH RUNWAY

13-05-2025
IND CLEARED FOR PAN-RAS MOLECULAR GLUE ERAS-0015 AND IND SUBMITTED FOR PAN-KRAS INHIBITOR ERAS-4001,...
Více zde

ERASCA TO PRESENT AT THE BANK OF AMERICA SECURITIES HEALTH CARE CONFERENCE

07-05-2025
SAN DIEGO, MAY 07, 2025 (GLOBE NEWSWIRE) -- ERASCA, INC. (NASDAQ: ERAS), A CLINICAL-STAGE PRECISION...
Více zde

ERASCA PRESENTS NEW PRECLINICAL DATA REINFORCING BEST-IN-CLASS POTENTIAL OF RAS-TARGETING FRANCHISE AT THE 2025 AACR ANNUAL MEETING

29-04-2025
ERAS-0015 AND ERAS-4001 SHOWED ROBUST ANTI-TUMOR ACTIVITY AS MONOTHERAPY AND COMBINATION THERAPY FIR...
Více zde

ERASCA ANNOUNCES THREE POSTER PRESENTATIONS AT THE 2025 AACR ANNUAL MEETING

25-03-2025
PRESENTATIONS WILL FEATURE POTENTIAL BEST-IN-CLASS PAN-RAS MOLECULAR GLUE ERAS-0015 AND PAN-KRAS INH...
Více zde

ERASCA REPORTS FOURTH QUARTER AND FULL YEAR 2024 BUSINESS UPDATES AND FINANCIAL RESULTS

20-03-2025
POTENTIALLY BEST-IN-CLASS RAS-TARGETING FRANCHISE ADVANCING WITH BOTH ERAS-0015 AND ERAS-4001 EXPECT...
Více zde

ERASCA TO PRESENT AT THE GUGGENHEIM SECURITIES SMID CAP BIOTECH CONFERENCE

31-01-2025
SAN DIEGO, JAN. 31, 2025 (GLOBE NEWSWIRE) -- ERASCA, INC. (NASDAQ: ERAS), A CLINICAL-STAGE PRECISI...
Více zde

ERASCA REPORTS THIRD QUARTER 2024 BUSINESS UPDATES AND FINANCIAL RESULTS

12-11-2024
POSITIVE PRELIMINARY PHASE 1B DATA IN SEACRAFT-1 NRASM MELANOMA COHORT BOLSTERS CONVICTION IN ONGOIN...
Více zde

ERASCA TO PRESENT AT UPCOMING INVESTOR CONFERENCES

05-11-2024
SAN DIEGO, NOV. 05, 2024 (GLOBE NEWSWIRE) -- ERASCA, INC. (NASDAQ: ERAS), A CLINICAL-STAGE PRECISIO...
Více zde

ERASCA REPORTS SECOND QUARTER 2024 BUSINESS UPDATES AND FINANCIAL RESULTS

12-08-2024
IN-LICENSED POTENTIAL BEST-IN-CLASS PAN-RAS MOLECULAR GLUE ERAS-0015 AND POTENTIAL FIRST-IN-CLASS PA...
Více zde

ERASCA TO PRESENT AT UPCOMING INVESTOR CONFERENCES IN JUNE

29-05-2024
SAN DIEGO, MAY 29, 2024 (GLOBE NEWSWIRE) -- ERASCA, INC. (NASDAQ: ERAS), A CLINICAL-STAGE PRECISION...
Více zde

ERASCA ANNOUNCES CLOSING OF UNDERWRITTEN OFFERING OF COMMON STOCK AND FULL EXERCISE OF THE UNDERWRITERS' OPTION TO PURCHASE ADDITIONAL SHARES

21-05-2024
SAN DIEGO, MAY 21, 2024 (GLOBE NEWSWIRE) -- ERASCA, INC. (NASDAQ: ERAS), A CLINICAL-STAGE PRECISION ...
Více zde

ERASCA ANNOUNCES STRATEGIC IN-LICENSING OF RAS-TARGETING FRANCHISE

16-05-2024
PAN-RAS MOLECULAR GLUE ERAS-0015 AND PAN-KRAS INHIBITOR ERAS-4001 ARE POTENT, ORAL INHIBITORS WITH P...
Více zde

ERASCA ANNOUNCES PRICING OF UNDERWRITTEN OFFERING OF COMMON STOCK

16-05-2024
SAN DIEGO, MAY 16, 2024 (GLOBE NEWSWIRE) -- ERASCA, INC. (NASDAQ: ERAS), A CLINICAL-STAGE PRECISION ...
Více zde

ERASCA REPORTS FIRST QUARTER 2024 BUSINESS UPDATES AND FINANCIAL RESULTS

08-05-2024
MEDIAN OS OF 13-14 MONTHS FOR NAPORAFENIB PLUS TRAMETINIB IN POOLED ANALYSIS OF PATIENTS WITH NRASM ...
Více zde

close

Datum Typ Otevřít EDGAR Stáhnout dokument
2026-01-29 00:00:008-KStáhnout
2026-01-22 00:00:008-KStáhnout
2026-01-20 00:00:008-KStáhnout
2026-01-12 00:00:008-KStáhnout
2025-11-12 00:00:008-KStáhnout
2025-11-12 00:00:0010-QStáhnout
2025-08-12 01:00:008-KStáhnout
2025-08-12 01:00:0010-QStáhnout
2025-08-12 00:00:008-KStáhnout
2025-08-12 00:00:0010-QStáhnout
2025-06-26 01:00:008-KStáhnout
2025-06-26 00:00:008-KStáhnout
2025-05-13 01:00:008-KStáhnout
2025-05-13 01:00:0010-QStáhnout
2025-05-13 00:00:008-KStáhnout
2025-05-13 00:00:0010-QStáhnout
2025-03-20 00:00:008-KStáhnout
2025-03-20 00:00:0010-KStáhnout
2025-03-19 23:00:008-KStáhnout
2025-03-19 23:00:0010-KStáhnout
2025-01-13 00:00:008-KStáhnout
2025-01-12 23:00:008-KStáhnout
2024-11-12 00:00:008-KStáhnout
2024-11-12 00:00:0010-QStáhnout
2024-11-11 23:00:008-KStáhnout
2024-11-11 23:00:0010-QStáhnout
2024-10-24 01:00:008-KStáhnout
2024-10-24 00:00:008-KStáhnout
2024-08-12 01:00:008-KStáhnout
2024-08-12 01:00:0010-QStáhnout
2024-08-12 00:00:008-KStáhnout
2024-08-12 00:00:0010-QStáhnout
2024-06-24 01:00:008-KStáhnout
2024-06-24 00:00:008-KStáhnout
2024-05-17 01:00:008-KStáhnout
2024-05-17 00:00:008-KStáhnout
2024-05-16 01:00:008-KStáhnout
2024-05-16 00:00:008-KStáhnout
2024-05-08 01:00:008-KStáhnout
2024-05-08 01:00:0010-QStáhnout
2024-05-08 00:00:008-KStáhnout
2024-05-08 00:00:0010-QStáhnout
2024-03-28 00:00:008-KStáhnout
2024-03-27 23:00:008-KStáhnout
2024-03-27 00:00:008-KStáhnout
2024-03-27 00:00:0010-KStáhnout
2024-03-26 23:00:008-KStáhnout
2024-03-26 23:00:0010-KStáhnout
2024-01-09 00:00:008-KStáhnout
2024-01-08 23:00:008-KStáhnout
2023-12-11 00:00:008-KStáhnout
2023-12-10 23:00:008-KStáhnout
2023-11-28 00:00:008-KStáhnout
2023-11-27 23:00:008-KStáhnout
2023-11-09 00:00:008-KStáhnout
2023-11-09 00:00:0010-QStáhnout
2023-11-08 23:00:008-KStáhnout
2023-11-08 23:00:0010-QStáhnout
2023-08-29 01:00:008-KStáhnout
2023-08-29 00:00:008-KStáhnout
2023-08-10 01:00:008-KStáhnout
2023-08-10 01:00:0010-QStáhnout
2023-08-10 00:00:008-KStáhnout
2023-08-10 00:00:0010-QStáhnout
2023-06-27 01:00:008-KStáhnout
2023-06-27 00:00:008-KStáhnout
2023-06-05 01:00:008-KStáhnout
2023-06-05 00:00:008-KStáhnout
2023-05-25 01:00:008-KStáhnout
2023-05-25 00:00:008-KStáhnout
2023-05-15 01:00:008-KStáhnout
2023-05-15 01:00:0010-QStáhnout
2023-05-15 00:00:008-KStáhnout
2023-05-15 00:00:0010-QStáhnout
2023-04-19 01:00:008-KStáhnout
2023-04-19 00:00:008-KStáhnout
2023-04-10 01:00:008-KStáhnout
2023-04-10 00:00:008-KStáhnout
2023-03-23 00:00:008-KStáhnout
2023-03-23 00:00:0010-KStáhnout
2023-03-22 23:00:008-KStáhnout
2023-03-22 23:00:0010-KStáhnout
2023-02-09 00:00:008-KStáhnout
2023-02-08 23:00:008-KStáhnout
2023-01-09 00:00:008-KStáhnout
2023-01-08 23:00:008-KStáhnout
2022-12-09 00:00:008-KStáhnout
2022-12-08 23:00:008-KStáhnout
2022-11-09 00:00:008-KStáhnout
2022-11-09 00:00:0010-QStáhnout
2022-11-08 23:00:008-KStáhnout
2022-11-08 23:00:0010-QStáhnout
2022-09-07 01:00:008-KStáhnout
2022-09-07 00:00:008-KStáhnout
2022-08-11 01:00:008-KStáhnout
2022-08-11 01:00:0010-QStáhnout
2022-08-11 00:00:008-KStáhnout
2022-08-11 00:00:0010-QStáhnout
2022-06-24 01:00:008-KStáhnout
2022-06-24 00:00:008-KStáhnout
2022-05-12 01:00:008-KStáhnout
2022-05-12 01:00:0010-QStáhnout
2022-05-12 00:00:008-KStáhnout
2022-05-12 00:00:0010-QStáhnout
2022-04-27 01:00:008-KStáhnout
2022-04-27 00:00:008-KStáhnout
2022-03-24 00:00:008-KStáhnout
2022-03-24 00:00:0010-KStáhnout
2022-03-23 23:00:008-KStáhnout
2022-03-23 23:00:0010-KStáhnout
2021-11-23 00:00:008-KStáhnout
2021-11-22 23:00:008-KStáhnout
2021-11-10 00:00:008-KStáhnout
2021-11-10 00:00:0010-QStáhnout
2021-11-09 23:00:008-KStáhnout
2021-11-09 23:00:0010-QStáhnout
2021-08-26 01:00:008-KStáhnout
2021-08-26 01:00:0010-QStáhnout
2021-08-26 00:00:008-KStáhnout
2021-08-26 00:00:0010-QStáhnout
2021-07-20 01:00:008-KStáhnout
2021-07-20 00:00:008-KStáhnout
preloader